摘要
睡眠在運動表現與代謝調節中扮演關鍵角色,而運動員在賽前因焦慮、時差或心理壓力,常出現急性睡眠障礙。研究指出,無論是部分或完全睡眠剝奪,皆與肌力、耐力、反應時間及認知功能下降相關。常用鎮靜安眠藥包括苯二氮平類與Z-drugs,兩者皆作用於γ-胺基丁酸A 型受體(gamma-aminobutyric acid type A receptor) 並增強抑制性神經傳導,可能影響反應時間與協調性,且其效應與半衰期與用藥時機相關。現有文獻顯示此類藥物對運動表現的影響報告不一,部分研究未觀察到負面影響,亦有研究指出殘餘鎮靜效應與表現下降,其差異可能來自藥物特性與試驗設計差異,尚難建立一致的結論。整體而言,睡眠剝奪明確不利運動表現,而鎮靜安眠藥雖可能改善睡眠,但其對表現的正向效益尚缺乏實證支持。建議運動醫療團隊優先採用非藥物介入(如:認知行為治療),以在安全前提下兼顧睡眠品質與運動表現。
ABSTRACT
Sleep plays a critical role in regulating athletic performance and metabolic functions. Athletes frequently experience acute sleep disturbances prior to competition, often due to anxiety, jet lag, or psychological stress. Studies have shown that both partial and total sleep deprivation are associated with declines in strength, endurance, reaction time, and cognitive performance. Commonly used sedative-hypnotics, including benzodiazepines and Z-drugs, act on gamma-aminobutyric acid type A receptors to enhance inhibitory neurotransmission, potentially impairing reaction time and motor coordination; their effects are closely related to drug half-life and timing of administration. Current literature presents inconsistent findings regarding the impact of these agents on athletic performance: some studies report no significant negative effects, while others indicate residual sedation and performance impairment. These discrepancies may stem from differences in drug properties, dosing regimens, and study designs. Overall, while sleep deprivation clearly detracts from athletic performance, the potential benefits of sedative-hypnotics in this context remain unproven. Therefore, it is recommended that sports medicine teams prioritize non-pharmacological interventions—such as cognitive behavioral therapy for insomnia—to improve sleep quality while preserving performance under safe and evidence-based conditions.
Submitted for publication: 2025.12.04; Accepted for publication: 2026.03.16